(Q35825529)

English

Donor leukocyte infusions in recurrent Hodgkin lymphoma following allogeneic stem cell transplant: 10-year experience at the M. D. Anderson Cancer Center

scientific article published on 5 January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Donor leukocyte infusions in recurrent Hodgkin lymphoma following allogeneic stem cell transplant: 10-year experience at the M. D. Anderson Cancer Center (English)

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Hodgkin lymphoma

1 reference

based on heuristic

inferred from title

object named as

Chitra M Hosing

9

0 references

8

object named as

Uday R Popat

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

2

object named as

Rima Saliba

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Richard E Champlin

15

object named as

Richard E Champlin

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

13

object named as

Sergio A Giralt

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

10

object named as

Yago Nieto

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Muzaffar Qazilbash

11

object named as

Muzaffar H Qazilbash

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Sandra A Acholonu

3

object named as

Sandra Acholonu

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Grace-Julia Okoroji

4

object named as

Grace-Julia Okoroji

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

5

object named as

Celina Ledesma

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

7

object named as

Roy Jones

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

author name string

Paolo Anderlini

1

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Borje S Andersson

6

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Naoto T Ueno

12

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Marcos J de Lima

14

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

publication date

5 January 2012

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

53

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

1239-1241

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Allogeneic transplantation for Hodgkin lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4493857

27 July 2018

'GVHD': graft-versus-host disease or graft-versus-Hodgkin's disease? An old acronym with new meaning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4493857

27 July 2018

Demonstration of durable graft versus lymphoma effects in Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.644547

21 January 2018

Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.644547

21 January 2018

Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcome

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.644547

21 January 2018

Donor lymphocyte infusions modulate relapse risk in mixed chimeras and induce durable salvage in relapsed patients after T-cell-depleted allogeneic transplantation for Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.644547

21 January 2018

Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.644547

21 January 2018

Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.644547

21 January 2018

Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.644547

21 January 2018

Donor leukocyte infusions in relapsed Hodgkin's lymphoma following allogeneic stem cell transplantation: CD3+ cell dose, GVHD and disease response

1 reference

https://pubmed.ncbi.nlm.nih.gov/22132837

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3109/10428194.2011.644547

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

10 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35825529&oldid=1977390344"